Potentially Resectable Locally Advanced Malignant Tumors of Biliary System
1 clinical trials · Condition
◉ Watch Potentially Resectable Locally Advanced Malignant Tumors of Biliary System
| Record | Firm | Date |
|---|---|---|
| Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. (NCT05036798) | Tianjin Medical University Cancer Institute and Hospital | 2021-09-17 |
Track Potentially Resectable Locally Advanced Malignant Tumors of Biliary System automatically
Every clearance here is in the API, with alerts when new ones post.